You have 9 free searches left this month | for more free features.

City

Beijing (1)

Burbank (1)

Minneapolis (1)

Salt Lake City (1)

Scottsdale (1)

Seattle (1)

Spokane (1)

Condition

Advanced Esophageal Carcinoma (1)

Appendiceal Cancer (1)

Colorectal Cancer (1)

Peritoneal Carcinoma (1)

Stage IV Pancreatic Cancer (1)

Overall Status

Completed (1)

Terminated (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Pancreatic Cancer Research Team (1)

Peking University (1)

University of Utah (1)

Collaborator

Intervention

mfolfiri (3)

folfirinox (1)

gemcitabine (1)

immunohistochemistry (ihc) analysis (1)

metformin (1)

nab-paclitaxel (1)

oxaliplatin (1)

Study Documents

Intervention Type

drug (3)

genetic (1)

Funder Type

Other (3)

Study Type

Interventional (3)

mfolfiri

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Colorectal Cancer, Appendiceal Cancer, Peritoneal Carcinoma Trial in Salt Lake City (Oxaliplatin, mFOLFIRI)

Terminated

Colorectal Cancer
+2 more

Oxaliplatin
mFOLFIRI

Salt Lake City, Utah

Huntsman Cancer Institute

Sep 21, 2021

Stage IV Pancreatic Cancer Trial in United States (Gemcitabine, nab-paclitaxel, FOLFIRINOX)

Completed

Stage IV Pancreatic Cancer

Gemcitabine
+5 more

Scottsdale, Arizona
+4 more

Aug 17, 2016

Advanced Esophageal Carcinoma Trial in Beijing (mFOLFIRI)

Unknown status

Advanced Esophageal Carcinoma

mFOLFIRI

Beijing, Beijing, China

Zhang Xiaodong

Jan 6, 2010